Dogs

SpotitEarly’s canine partners are at the heart of its early cancer detection platform. This article explores how the dogs are selected, trained, and cared for, and the science behind their extraordinary ability to detect cancer through scent. Learn about their daily work alongside handlers, the role they play in the hybrid canine-AI detection process, and how their skills contribute to making cancer screening accurate, non-invasive, and accessible.

Breath analysis is transforming the landscape of early cancer detection. By identifying volatile organic compounds (VOCs) in exhaled air, this non-invasive method can reveal disease indicators long before symptoms appear. This article explains the science behind breath-based biomarkers, how SpotitEarly integrates them with canine scent detection and AI, and why this approach offers accuracy, comfort, and scalability for global screening.

SpotitEarly’s LUCID bio-hybrid platform unites the natural sensitivity of trained detection dogs with the precision of artificial intelligence. This article explores how the system captures and analyzes breath samples, integrates biological and technological strengths, and delivers accurate, scalable early cancer detection. Learn how LUCID is redefining what’s possible in non-invasive cancer screening.

The recent Rainbow clinical study, published in Nature Scientific Reports, showcases SpotitEarly’s extraordinary success. It shows SpotitEarly is able to detect cancer at early stages with sensitivity rates exceeding 90% for multiple cancers, including those with no standard screening options available today. This breakthrough positions SpotitEarly as a world leader in early disease detection technology.

Artificial intelligence is at the core of SpotitEarly’s bio-hybrid AI platform, refining and validating results from canine scent detection to ensure accuracy and scalability. This article explores how AI models process complex data, integrate it with clinical workflows, and evolve it over time. By combining canine’s abilities with cutting-edge machine learning, SpotitEarly aims to make early cancer screening more precise, accessible, and widely adopted.

Dogs possess an extraordinary sense of smell — capable of detecting volatile organic compounds linked to cancer at concentrations humans cannot perceive. This article will explain the biology of canine olfaction, the research behind scent-based cancer detection, and how SpotitEarly plans to train dogs as part of a hybrid platform with AI to make early, non-invasive cancer screening possible on a global scale.